We are live on
!
Find out more
SCM
Seascape Capital Management Portfolio holdings
AUM
$417M
1-Year Est. Return
41.98%
This Fund
S&P 500
This Quarter
Est. Return
-11.67%
1 Year Est. Return
+41.98%
3 Year Est. Return
+111.01%
5 Year Est. Return
+122.53%
10 Year Est. Return
–
AUM
$165M
AUM Growth
-$28M
(-15%)
Cap. Flow
-$4.32M
Cap. Flow
% of AUM
-2.62%
Top 10 Holdings %
Top 10 Hldgs %
36.6%
Holding
88
New
6
Increased
45
Reduced
29
Closed
4
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Weyerhaeuser
WY
|
+$1.95M |
| 2 |
Johnson & Johnson
JNJ
|
+$363K |
| 3 |
Pfizer
PFE
|
+$264K |
| 4 |
M&T Bank
MTB
|
+$240K |
| 5 |
Bristol-Myers Squibb
BMY
|
+$239K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Newmark Group
NMRK
|
+$2.9M |
| 2 |
PIMCO Active Bond Exchange-Traded Fund
BOND
|
+$2.89M |
| 3 |
EPAY
Bottomline Technologies Inc
EPAY
|
+$1.3M |
| 4 |
SCHR
Schwab Intermediately-Term US Treasury ETF
SCHR
|
+$447K |
| 5 |
First Trust Smith Opportunistic Fixed Income ETF
FIXD
|
+$331K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.08% |
| 2 | Healthcare | 12.05% |
| 3 | Financials | 8.79% |
| 4 | Industrials | 8.08% |
| 5 | Consumer Staples | 6.6% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
76
Eli Lilly
LLY
$1.06T
| $267K | 0.16% |
822
+6
| +0.7% | +$1.8K |
|
77
iShares Core S&P US Growth ETF
IUSG
$33.9B
| $261K | 0.16% |
3,122
+3
| +0.1% | +$275 |
|
78
Home Depot
HD
$355B
| $260K | 0.16% |
949
+3
| +0.3% | +$886 |
|
|
79
Bristol-Myers Squibb
BMY
$132B
| $242K | 0.15% |
+3,138
| New | +$239K |
|
80
iShares Core S&P Small-Cap ETF
IJR
$112B
| $240K | 0.15% |
2,594
| – | – |
|
81
Berkshire Hathaway Class B
BRK.B
$1.13T
| $239K | 0.15% |
875
-13
| -1% | -$4.08K |
|
82
iShares 1-5 Year Investment Grade Corporate Bond ETF
IGSB
$23.3B
| $233K | 0.14% |
+4,600
| New | +$234K |
|
|
83
M&T Bank
MTB
$36.2B
| $227K | 0.14% |
+1,426
| New | +$240K |
|
84
iShares Broad USD Investment Grade Corporate Bond ETF
USIG
$17.4B
| $206K | 0.13% |
+4,050
| New | +$211K |
|
85
Allegro MicroSystems
ALGM
$8.16B
| – | – |
-8,170
| Closed | -$232K |
|
|
MPT
86
Medical Properties Trust
MPT
$2.81B
| – | – |
-14,897
| Closed | -$315K |
|
|
87
Newmark Group
NMRK
$2.63B
| – | – |
-182,230
| Closed | -$2.9M |
|
|
EPAY
88
DELISTED
Bottomline Technologies Inc
EPAY
| – | – |
-23,000
| Closed | -$1.3M |
|
Similar funds
ACM
MCM
FFA
TI
VIS
PIMC
DBRC
MMG
Seascape Capital Management's Q2 2022 Portfolio in Review
As of Q2 2022, Seascape Capital Management held 88 positions worth $165M, down 15% from $193M the previous quarter. Its ten largest holdings account for 37% of the portfolio.
Seascape Capital Management's Q2 2022 filing shows 6 new, 45 increased, 29 reduced and 4 closed positions. Its largest new stake was Weyerhaeuser: 51,164 shares worth $1.7M. The largest sale was Newmark Group, an estimated $2.9M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 21% a quarter earlier, followed by Healthcare and Financials.
- Seascape Capital Management's largest Q2 2022 buy was Weyerhaeuser: 51,164 shares worth $1.7M.
- Seascape Capital Management added most to Pfizer in Q2 2022, an estimated $264K increase.
- Seascape Capital Management's biggest Q2 2022 reduction was PIMCO Active Bond Exchange-Traded Fund, cutting an estimated $2.89M.
- Seascape Capital Management fully exited Newmark Group in Q2 2022, selling an estimated $2.9M.
- Seascape Capital Management's ten largest holdings make up 37% of its $165M portfolio in Q2 2022.
- Seascape Capital Management opened 6 new positions and closed 4 in Q2 2022.
- Seascape Capital Management's portfolio value fell 15% quarter-over-quarter to $165M.
Based on Seascape Capital Management's 13F filing for Q2 2022, filed 9 Aug 2022.